Abstract: Behcet’s Unite, Shariati Hospital the aim to propose a scoring system for the treatment of the ocular inflammation one vasculitis by our medications and to evaluate the state of the activity of the eye. Eleven activity and five chronicity (constant) parameters are scored from zero to four to consider the condition of each eye. The activity variables are: episcleritis &/or scleritis, anterior uveitis, hyalites, IMU, central periphlebitis &/or thrombosis, central periartertis, peripheral ...
Abstract: Introduction: Opthalmologic manifestations are the major cause of morbidity in Behcet’s Disease. If not treated, they usually progress toward sever loss of vision or blindness. Cytotoxic drugs are the main therapeutic agents. Materials & Methods: In an open, non randomized, control study, pulse cyclophosphamide (PCP), low dose pulse cyclophosphamide (LDP), weakly methtrexate (MTX), chlorambucil (CHL), oral cyclophosphamide (OCP), and cyclosporine A (CYA) were used in a standard protocol for 778 patients. ...
Abstract: Introduction: Ocular lesions are the major cause of morbidity in Behcet’s Disease. If not treated they usually progress toward severe loss of vision or blindness. Cytotoxic drugs are the main therapeutic arsenal used for this condition. Materials & Methods: In an open, non randomized control study, pulse Cyclophosphamide (PCP), low dose pulse cyclophosphamide (LDP), oral cyclophosphamide (OCP), weakly methotrexate (MTX), chlorambucil (CHL), and cyclosporine A (CYA) were used in a standard ...
Abstract: Neuropsychiatric manifestations of SLE are frequent and usually serious, convulsion is one of the most important and hazardous symptoms of CNS-LUPUS. Because there are many differences in clinical manifestations frequency and severity of organ systems involvement, and cause of death in patients with SLE (in Iran and other countries) an analytic retrospective case-control study was carried out to evaluate the frequency of convulsion in relation with age and sex distribution, ...
Abstract: There are only two nationwide surveys of Behcet's Disease (BD) in the world, one from Japan and one from Iran. The comparison of the two surveys is interesting because the populations are racially different, although they share same genetic background via the invasion of Iran by Turk tribes (from the northem part of China) in the 10 th and 13 th century. The annual incidence of BD in Iran is 350 ...
Abstract: Introduction: BMD varies in different countries due to different genetic and environmental factors, It is necessary to determine BMD in normal population of Iran. This study was designed by the Rheumatology Research Center to fulfill this task. It was achieved by a grant from the Deputy Ministry for Research, the Ministry of Health, Treatment and Medical Education. Materials and methods: 280 normal Iranians were selected randomly from staffs of Shariati Hospital ...
Abstract: In order to study a possible relation between mechanical bone pains and the BMD, 1335 patients were analyzed as every consecutive patient. The BMD was measured in a cohort study on 5927 patients referred for various reasons to the Rheumatology Research Center, Osteoporosis Unit. The BMD was measured by Dual Energy X-rays Absorptiometry (DEXA) on the lumbar spine (L1-L4) and the femoral neck. Patients having an inflammatory disease such as ...
Abstract: Menopause is one of the most important accelerating factors of bone loss in women. This study was designed to evaluate the effects of the age of menopause on BMD in Iranian women. The women referred for Bone Densitometry who were menopaused and did not have hysterectomy before their menopause were selected as every consecutive patient. Those who had any other risk factor for osteoporosis were excluded. The patients were divided ...
Abstract: In Rheumatoid Arthritis (RA) osteoporosis is secondary. Its cause and its treatment are still controversial. All agents used in post menopausal osteoporosis have been tried for RA osteoporosis. Our work is a prospective open study to demonstrate the efficacy of low dose NF (20 mg daily) in these patients. Sixty two patients with RA and osteoporosis (t score less than 2.5 standard deviation, as defined by WHO) entered the study. BMD ...
Abstract: Natrium Fluoride (NF) is one of the best treatments of osteoporosis because it is cheap, it has no major side effects, and it is effective (Heany et al., Farley et al., Dure-Smith et al., Kanis et al., and Pak et al.). Our work is a prospective open study to demonstrate the efficacy of low dose NF (20 mg daily) in post menopausal osteoporosis. Fifty six patients with osteoporosis (t score less ...